57 studies found for:    Open Studies | "Adenoviridae Infections"
Show Display Options
Rank Status Study
21 Not yet recruiting Systemic Chemotherapy Combined With Recombinant Human Adenovirus Type 5 and Endostatin Injections for Treatment Malignant Hydrothorax in NSCLC Patients
Conditions: Malignant Hydrothorax;   Non Small Cell Lung Cancer
Interventions: Drug: Gemcitabine;   Drug: Vinorelbine;   Drug: Paclitaxel;   Drug: Pemetrexed;   Drug: Oncorine;   Drug: Endostar;   Drug: Cisplatin
22 Recruiting Anti-virus Treatment Following Bone Marrow Transplant
Conditions: Allogeneic Stem Cell Transplant;   Viral Infection;   Viral Reactivation
Intervention: Biological: Viral specific CTL Infusion
23 Recruiting Phase 1 Trial of Interleukin 12 Gene Therapy for Locally Recurrent Prostate Cancer
Condition: Prostate Cancer
Intervention: Biological: Ad5-yCD/mutTKSR39rep-hIL12
24 Recruiting Multivirus-specific T Cells for the Treatment of Virus Infections After Stem Cell Transplant
Condition: Infection
Intervention: Biological: Multivirus Specific T cells
25 Recruiting DNX-2401 With Interferon Gamma (IFN-γ) for Recurrent Glioblastoma or Gliosarcoma Brain Tumors
Condition: Glioblastoma or Gliosarcoma
Interventions: Drug: Single intratumoral injection of DNX-2401;   Drug: Interferon-gamma
26 Unknown  ADenoVirus Initiative Study in Epidemiology in Spain
Condition: Viral Conjunctivitis
Intervention:
27 Unknown  ADenoVirus Initiative Study in Epidemiology in Germany
Condition: Viral Conjunctivitis
Intervention:
28 Recruiting Study of a Recombinant Adenovirus to Treat Localized Prostate Cancer
Condition: Localized Prostate Cancer
Intervention: Drug: Ad5-SGE-REIC/Dkk3
29 Recruiting Safety Study of a Disrupted Adenovirus (Ad) Serotype Cocaine Vaccine for Cocaine-dependent Individuals
Condition: Cocaine Dependence
Interventions: Biological: dAd5GNE Vaccine;   Biological: Placebo
30 Recruiting Multivirus-specific Cytotoxic T Lymphocytes (mCTL)
Condition: Refractory Viral Infections
Intervention: Biological: mCTLs
31 Unknown  Trial of E10A in Head and Neck Cancer
Conditions: Head and Neck Squamous Carcinoma;   Nasopharyngeal Carcinoma
Interventions: Drug: E10A;   Drug: Cisplatin;   Drug: Paclitaxel
32 Not yet recruiting A Study to Evaluate the Safety and Immunogenicity of a Candidate Ebola Vaccine in Adults
Condition: Virus Diseases
Interventions: Biological: GlaxoSmithKline (GSK) Biologicals' investigational recombinant chimpanzee adenovirus Type 3-vectored Ebola Zaire vaccine (ChAd3-EBO-Z) (GSK3390107A);   Drug: Placebo
33 Recruiting A Study to Evaluate the Safety and Immunogenicity of a Candidate Ebola Vaccine in Children
Condition: Virus Diseases
Interventions: Biological: GlaxoSmithKline (GSK) Biologicals' investigational recombinant chimpanzee adenovirus Type 3-vectored Ebola Zaire vaccine (ChAd3-EBO-Z) (GSK3390107A);   Biological: Nimenrix powder and solvent for solution for injection in pre-filled syringe; Meningococcal group A, C, W-135 and Y conjugate vaccine
34 Recruiting Allogeneic Virus-specific T Cell Lines (VSTs)
Condition: Viral Infections After HSCT
Intervention: Biological: VSTs
35 Recruiting A Phase I Dose Escalation Study of Intratumoral VCN-01 Injections With Gemcitabine and Abraxane® in Patients With Advanced Pancreatic Cancer
Conditions: Pancreatic Adenocarcinoma;   Metastatic Pancreatic Adenocarcinoma
Interventions: Genetic: VCN-01;   Drug: Gemcitabine;   Drug: Abraxane®
36 Recruiting Gene Therapy Study in Severe Haemophilia A Patients
Condition: Severe Haemophilia A
Intervention: Genetic: BMN 270
37 Recruiting Phase I Dose Escalation Study of Intravenous VCN-01 With or Without Gemcitabine and Abraxane® in Patients With Advanced Solid Tumors
Conditions: Locally Advanced Solid Tumors;   Metastatic Solid Tumors;   Pancreatic Adenocarcinoma
Interventions: Genetic: VCN-01;   Drug: Gemcitabine;   Drug: Abraxane®
38 Unknown  Study of Treatment and Metabolism in Patients With Urea Cycle Disorders
Condition: Amino Acid Metabolism, Inborn Errors
Interventions: Behavioral: Protein and calorie controlled diet;   Genetic: Ornithine transcarbamylase vector
39 Recruiting GVAX vs. Placebo for MDS/AML After Allo HSCT
Conditions: Myelodysplastic Syndrome;   Acute Myeloid Leukemia
Interventions: Biological: GVAX;   Biological: Placebo Vaccine;   Procedure: Allogeneic Hematopoietic Stem Cell Transplant;   Drug: Busulfan;   Drug: Fludarabine;   Drug: Tacrolimus;   Drug: Methotrexate
40 Not yet recruiting Administration of AdVEGF-All6A+ to Myocardium of Individuals With Diffuse CAD Via Minimally Invasive Surgery
Condition: Coronary Artery Disease
Interventions: Biological: AdVEGF-All6A+;   Biological: AdNull

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-57) Show next page of results    Last Page
Indicates status has not been verified in more than two years